Indian Great Cormorant or Indian cormorant(Phalacrocorax fuscicollis) are a member of the greedy family. It is found mainly along the inland waters of the Indian Subcontinent, but spreads westward to Sind and eastward to Thailand and Cambodia. It is a gregarious species that can be easily distinguished from a similar sized Javanese cormorant by its blue eyes, small head with a sloping forehead and a long, narrow bill ending in a hooked tip.
This medium-sized bronze brown cormorant is serrated in black on the upper plumage, lacks a ridge and has a small and slightly pointed head with a long, narrow bill that ends at a hooked tip. Eye - Blue and bare yellow facial skin during non-breeding season. Nesting birds have a short white ear tuft. In some plumages it has a white throat, but the white is limited below the yawn in contrast to that in the much larger grand greedy. The sexes are similar but non-breeding adults and the adolescents are darker.
Habitat and distribution
This greedy fish is sociable in the inland rivers or large wetlands of peninsular India and northern Sri Lanka. It also occurs in estuaries and mangroves, but not on the open coast. They breed very locally in mixed colonies of species. They extend northeast to Assam and eastward to Thailand, Burma and Cambodia.
The breeding season is July to February, but depends on rainfall and water conditions. In northern India, they breed from July to February and in Sri Lanka between November and February. The nest is a platform of branches placed in the forks of partially submerged trees or those that grow on islands. Nests are placed in close proximity to those of other Indian cormorants, storks or waterbirds in dense colonies, often with several rows of nests. The usual clutch is three to five eggs, which are bluish green and chalky.
The Indian Greedy makes short dives to capture fish and the group will often fish together, forming a wide front to corner the fish.
First on mice, and now on Ukrainians
Vaccination in Ukraine began on February 24 - an airplane from India brought 500 thousand doses of CoviShield vaccine to Kiev.
CoviShield is reported to be the Indian counterpart of the AstraZeneca vaccine. The company entered into an agreement with the Serum Institute of India to manufacture its covid vaccine last year.
The response to initiation of vaccination with the drug was mixed. Former deputy of the Verkhovna Rada Alexey Zhuravko stated that at first the drug was tested on laboratory mice, and now on Ukrainians. So Kiev began a kind of "vaccination for the poor" campaign, he summed up.
Meanwhile, the Ukrainian government expects that up to 22 million citizens will be vaccinated by the end of 2022. According to the Ministry of Digital Transformation of Ukraine, more than 100 thousand Ukrainians of different ages have already signed up for the queue. It was opened on March 1.
"There is no need to please yourself with illusions ..."
However, in a week of vaccination against covid in Ukraine (about ten thousand people have already received the Indian drug), experts have recorded more than a hundred cases of side effects. One person was admitted to the hospital in serious condition.
126 reports of side effects were recorded, that is, just over 1% of all vaccinated. One case was qualified as serious and (it was he) that led to the hospitalization of a person, -
noted the chairman of the parliamentary committee on the health of the nation, health care and health insurance Mikhail Radutsky on your Facebook.
According to reports on social networks, many Ukrainians are quite skeptical about the vaccination campaign in the country. Some are openly afraid of the drug brought from Asia. Which is not surprising: against the background of the growing number of vaccinated people with side effects, there are also not encouraging statements from the authorities.
"There is no need to please yourself with the illusion that the vaccine will save," the prime minister said Denis Shmygal, who reported on the impending third wave of the pandemic in Ukraine.
The politician supplied his pessimistic statements with a promise to introduce a full lockdown. Say, it will be more reliable this way.
The pain begins at the injection site ...
The official reports do not specify exactly what side effects the Ukrainians who have been vaccinated are faced with.
Meanwhile, according to the doctor who took CoviShield, the side effects appeared the next day in almost every tenth vaccinated physician from the institution where she works. Vesti.ua writes about this without disclosing the source.
Pain occurs at the injection site. The next day I had a temperature of 38-39. There was even 39.2. I periodically knocked her down. This is a normal process, there is an immune inflammation, antibodies are produced. Of all my vaccinated colleagues, who are about 30 people, only three had such a reaction,
- notes the interlocutor Vesti.ua.
In addition to high fever, urticaria may also occur - this is an acute allergic reaction. It is noted that in this case, the person is unlikely to receive a second dose.
"Quality vaccines - for the money"
Added fuel to the fire by a pediatrician of the highest category, candidate of medical sciences, writer and TV presenter Evgeny Komarovsky, calling Ukraine just at the start of vaccination "underdeveloped" country. He stated this in an interview. Dmitry Gordon on the YouTube channel.
Dr. Komarovsky also compared the standard of living in Ukraine with India, noted the successes of the South Asian country, including in the field of industry, rocketry, IT and healthcare. The TV presenter recalled that India produces 65% of the world's vaccines.
The doctor also evaluated the Indian vaccine against coronavirus CoviShield, calling the drug effective - it exceeds 60% in protection against coronavirus, and 90% against severe forms of the disease, Yevgeny Komarovsky said.
The doctor added that it is necessary to use the vaccine available now (that is, CoviShield), "since the mass access of Ukrainian residents to high-quality vaccines, which the leading countries are now purchasing, will not appear until mid-August or September and will be paid for." The doctor stated this on his Instagram account.
The doctor also appreciated the Russian Sputnik V vaccine.
For the doctor, medications are divided into those that treat and those that do not. I admit that Sputnik V is a very good vaccine,
- noted Evgeny Komarovsky.
Meanwhile, while in Ukraine they are experimenting with the Indian analogue of AstraZeneca, in Austria they decided to suspend the use of the vaccine produced, in fact, AstraZeneca. The decision was made after a 49-year-old woman who had received the vaccine died due to severe bleeding disorders, and a 35-year-old woman developed pulmonary embolism. However, foreign doctors believe that so far "there is no evidence of a causal relationship with vaccination." Whether this is so, time will tell.
At the same time, more and more countries are registering the Russian Sputnik V vaccine. No significant side effects of the drug have been reported.